Italy - Medical equipment, pharmaceuticals and personal care products

For more information and to make a bid you will need to go to the third party website.

Details

Provided by Open Opps
Opportunity closing date
06 July 2020
Opportunity publication date
27 May 2020
Category
33000000: Medical equipments, pharmaceuticals and personal care products
Value of contract
£1m-5m
Your guide to exporting
Report opportunity

Description

Three-year supply of enteral nutrition blends and oral nutritional supplements and bags for parenteral nutrition vitamin complexes and trace elements.
Liquid polymeric, normocaloric, normoprotein, fibre-free, ready-to-use, ready-to-use probe pack; for patients with normal nutritional needs; caloric intake required between 0.9 Kcal/ml and 1.2 Kcal/ml; protein: 15-16 %; osmolarity ≤ 260 mOsm/litre. Fibres absent. Fibre-free, semi-elemental liquid mixture, to be administered by probe, hyper caloric and hyperproteic, added in EPA and DHA, for critical hypercatabolic patients; required caloric intake ≥ 1,4 kcal/ml approximately; protein 25-26 %; fibre absent. Liquid polymeric, normo-caloric, normoprotein, soluble and insoluble fibre mixture, to be administered by probe, for normo-catabolic patients with normal nutritional requirements. Liquid polymeric, normocaloric, normocaloric, balanced, gluten-free, fiber-insoluble, liquid mix, to be administered by probe, indicated in patients with diabetes mellitus or glucose intolerance. Liquid polymeric, normocaloric, hyperproteic, liquid mixture, to be administered by probe, enriched in immunomodulants (omega 3, arginine, zinc); for critical hypercatabolic patients and with one or more risk factors for immunodepression, treatment of pressure sores. Liquid oligomeric, normoprotein, whey protein based, hypolipidicaric acid in oligopeptides and MCT, to be administered by probe, for patients with digestion and absorption problems. Liquid mixture to be administered by probe and by os, polymeric, hypercaloric, fiber-free, suitable for patients with renal failure, in dialysis treatment, ready to use. Liquid mixture to be administered by probe and os, polymeric, hypercaloric, hypoproteic, low mineral and phosphorus content, indicated in patients with renal failure. Liquid nutritional supplement, administered by os, hyperproteic, indicated in patients with diadiabetics, gluten-free, with fibre, available in assorted flavours. Liquid nutritional supplement administered by os, immunomodulating, for patients who are candidates for surgery, with added arginine, Omega 3 and nucleotides, and with soluble fiber PHGG. Oral, hypercaloric, semi-solid semi-solid hyperproteic nutritional supplement with creamy consistency in jars for patients with dysphagia and malnutrition. Oral, liquid, hypercaloric nutritional supplement for patients with high caloric requirements. Powder supplement to be reconstituted based on L-arginine, L-glutamine and immunonutrients, indicated for patients with pressure injuries and for the reintegration of lean mass. Gelled drink for or for dysphagic patients, sugar-free, with guarantee of homogeneous bolus, ready to use. Gelled drink for dysphagic patients, sugar-free, with guarantee of homogeneous bolus, ready to use. Nutritional supplement hyperproteic, hyperproteic, hypolipidic, powdered, per os rich in vitamins and minerals. Polymeric dietary food powder enriched in TGF-BETA 2 for patients with chronic inflammatory bowel disease (MICI). High-calorie liquid oral nutritional supplement designed for hepatopathopathic patients, rich in AAR and MCT. Hypercaloric liquid oral nutritional supplement designed for patients at risk of malnutrition and with acute and chronic respiratory failure. Oral Nutritional supplement in hypercaloric hyperproteic powder with essential AA, vit. D and calcium. Oral protein powder ntegrator. Protein ≥ 95%. Instant thickener in powder, based on xanthan gum, for liquid and semi-liquid foods, hot and cold, without taste modification, per os, for dysphagic patients. Complete enteral mixture for probe indicated in cases of acute and/or chronic pulmonary insufficiency. Complete enteral mixture for probe indicated in cases of acute and/or chronic hepatic insufficiency. Parenteral nutrition bags for peripheral vein with electrolytes. Parenteral nutrition bags for central double compartment vein without nitrogen electrolytes. Parenteral nutrition bags for double compartment central vein with nitrogen electrolytes. Parenteral nutrition bags for triple compartment central vein with nitrogen electrolytes. Parenteral nutrition bags for triple compartment central vein with electrolytes. Parenteral nutrition bags for triple compartment central vein without electrolytes. Water-soluble + fat-soluble adult vitamins to add in NPT bag without vitamin k. Ternary mixture for total parenteral nutrition, containing glucose, amino acids, lipids and electrolytes, in triple compartment bag. 5.3 % essential L-amino acids solution, intravenous use. Balanced solution of 10 % essential and non-essential L-amino acids, intravenous use. 4 % branched L-amino acids solution, intravenous use. 20 % fat emulsions, enovenous use, containing: olive oil, seed oil, medium chain triglycerides, fish oil enriched in omega 3.

Opportunity closing date
06 July 2020
Value of contract
£1m-5m

About the buyer

Address
IRCCS Lazzaro Spallanzani via Portuense 292 Roma 00149 Italy
Contact
cinzia.fiori@inmi.it

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?